Hyperbaric Oxygen, Neutrophil-oxidative Burst, and Cytokines
Status: | Recruiting |
---|---|
Conditions: | Infectious Disease |
Therapuetic Areas: | Immunology / Infectious Diseases |
Healthy: | No |
Age Range: | 18 - 65 |
Updated: | 3/3/2019 |
Start Date: | April 2015 |
End Date: | December 2019 |
Contact: | Lindell K Weaver, MD |
Email: | lindell.weaver@imail.org |
Phone: | 801-408-3623 |
Hyperbaric Oxygen, Neutrophil-oxidative Burst, and Cytokines: a Pilot Study
In this small pilot study, participants (patients and healthy volunteers) will have blood
drawn before and after the study intervention (hyperbaric chamber session or normal pressure
oxygen breathing. This blood will be analyzed for neutrophil oxidative burst and cytokine
analysis.
drawn before and after the study intervention (hyperbaric chamber session or normal pressure
oxygen breathing. This blood will be analyzed for neutrophil oxidative burst and cytokine
analysis.
The investigators are interested in studying the influence of hyperbaric oxygen on
neutrophils (a kind of white blood cell) and cytokines (cell proteins). Hyperbaric oxygen can
enhance the way the immune system works, but the investigators don't fully know how that
happens. the investigators are doing this study to learn more about this question.
neutrophils (a kind of white blood cell) and cytokines (cell proteins). Hyperbaric oxygen can
enhance the way the immune system works, but the investigators don't fully know how that
happens. the investigators are doing this study to learn more about this question.
Cohort 1: Diabetic hyperbaric patients with active, chronic infection
Inclusion Criteria:
- Adult patients (ages 18-65) presenting for an anticipated course of at least 4
hyperbaric oxygen sessions for chronic clinical indications (possible indications
include diabetic lower extremity wounds or refractory osteomyelitis)
- Diabetes mellitus
- Current antibiotic use for active infection
Exclusion Criteria:
- Prior treatment with hyperbaric oxygen within the last 30 days
- Consistent vitamin C or vitamin E supplementation in the past year
- Active tobacco use
- Pregnancy
Cohort 2: Hyperbaric patients without diabetes or active infection
Inclusion Criteria:
- Adult patients (ages 18-65) presenting for an anticipated course of at least 4 hyperbaric
oxygen sessions for chronic clinical indications (possible indications include crush
injury, acute peripheral arterial insufficiency, or radiation necrosis)
Exclusion Criteria:
- Prior treatment with hyperbaric oxygen within the last 30 days
- Consistent vitamin C or vitamin E supplementation in the past year
- Active tobacco use
- Pregnancy
- Diabetes mellitus
- Known or suspected viral or bacterial infection
Cohort 3: Critically ill hyperbaric patients with acute infection
Inclusion Criteria:
- Adult patients (ages 18-65) admitted to the intensive care unit for acute,
life-threatening infection where hyperbaric oxygen is clinically indicated for at least 4
sessions (possible indications include gas gangrene or necrotizing fasciitis)
Exclusion Criteria:
- Prior treatment with hyperbaric oxygen within the last 30 days
- Consistent vitamin C or vitamin E supplementation in the past year
- Active tobacco use
- Pregnancy
Cohort 4:
Carbon monoxide-poisoned patients
Inclusion Criteria:
- Adult patients (ages 18-65) presenting for hyperbaric oxygen for acute carbon monoxide
poisoning (up to 3 sessions)
Exclusion Criteria:
- Prior treatment with hyperbaric oxygen within the last 30 days
- Consistent vitamin C or vitamin E supplementation in the past year
- Active tobacco use
- Pregnancy
- Time interval between removal from carbon monoxide source and first hyperbaric oxygen
session >12 hours
Cohort 5: Diabetic research subjects also undergoing glucose tolerance testing
Inclusion Criteria:
- Co-enrollment in glucose tolerance testing study
- Meet inclusion/exclusion profile for that study
Exclusion Criteria:
- Prior treatment with hyperbaric oxygen within the last 30 days
- Consistent vitamin C or vitamin E supplementation in the past year
- Active tobacco use
Cohort 6: Brain injury research subjects
Inclusion Criteria:
- Co-enrollment in brain injury study
- Meet inclusion/exclusion profile for that study
Exclusion Criteria:
- Known or suspected viral or bacterial infection
- Consistent vitamin C or vitamin E supplementation in the past year
- Active tobacco use
Cohort 7: Hyperbaric chamber inside attendants
Inclusion Criteria:
- Employees (ages 18-65) medically cleared to work as hyperbaric chamber inside attendants,
reporting for a regular duty day
Exclusion Criteria:
- Known or suspected viral or bacterial infection
- Consistent vitamin C or vitamin E supplementation in the past year
- Active tobacco use
- Prior work in the hyperbaric chamber in the last 72 hours
Cohort 8: Healthy volunteers to receive hyperbaric oxygen
Inclusion Criteria:
- Healthy volunteers (ages 18-65)
- Medical clearance for hyperbaric oxygen exposure
Exclusion criteria:
- Hyperbaric oxygen exposure within the last 30 days
- Active chronic medical condition
- Use in the past 30 days of any over-the-counter or prescription medication or dietary
supplement beyond a general multivitamin
- Active tobacco use
- History of significant health problems, including metabolic bone disease, skeletal
muscle pathologies, cardiac or peripheral cardiovascular system abnormalities,
clotting disorders, coronary artery disease, peripheral vascular disease, stroke,
cancer, high cholesterol or triglycerides, high blood pressure, diabetes mellitus, or
impaired liver/kidney function.
- Morbidly obese (body mass index > 40 kg/m2)
- Pregnancy
- Known or suspected viral or bacterial infection
Cohort 9: Healthy volunteers to breathe 100% oxygen at atmospheric pressure
Inclusion Criteria:
- Healthy volunteers (ages 18-65)
Exclusion criteria:
- Hyperbaric oxygen exposure within the last 30 days
- Active chronic medical condition
- Use in the past 30 days of any over-the-counter or prescription medication or dietary
supplement beyond a general multivitamin
- Active tobacco use
- History of significant health problems, including metabolic bone disease, skeletal
muscle pathologies, cardiac or peripheral cardiovascular system abnormalities,
clotting disorders, coronary artery disease, peripheral vascular disease, stroke,
cancer, high cholesterol or triglycerides, high blood pressure, diabetes mellitus, or
impaired liver/kidney function.
- Morbidly obese (body mass index > 40 kg/m2)
- Pregnancy
- Known or suspected viral or bacterial infection
We found this trial at
2
sites
Salt Lake City, Utah 84143
Principal Investigator: Lindell K Weaver, MD
Phone: 810-408-3623
Click here to add this to my saved trials
5121 S Cottonwood St
Murray, Utah 84157
Murray, Utah 84157
(801) 507-7000
Principal Investigator: Lindell K. Weaver, MD
Phone: 801-408-3623
Intermountain Medical Center Intermountain Medical Center is one of the most technologically advanced and patient-friendly...
Click here to add this to my saved trials